BIRC5 expression is a poor prognostic marker in Ewing sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BIRC5 expression is a poor prognostic marker in Ewing sarcoma

Published:2012-09-07 Issue:1 Volume:60 Page:35-40
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Hingorani Pooja,Dickman Paul,Garcia-Filion Pamela,White-Collins Andrea,Kolb Edward A.,Azorsa David O.

Funder

Phoenix Children's Hospital Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24290/fullpdf

Reference40 articles.

1. Targeting insulin-like growth factor 1 receptor in sarcomas;Scotlandi;Curr Opin Oncol,2008

2. Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation;Mateo-Lozano;Oncogene,2003

3. Vascular endothelial growth factor: A therapeutic target for tumors of the Ewing's sarcoma family;Dalal;Clin Cancer Res,2005

4. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma;Ambrosini;Nat Med,1997

5. Survivin, versatile modulation of cell division and apoptosis in cancer;Altieri;Oncogene,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic characteristics of a six-gene signature based on ssGSEA in sarcoma;Aging;2024-01-17

2. Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment;Journal of Cancer Research and Clinical Oncology;2021-12-03

3. Prognostic significance of survivin expression in pediatric ewing sarcoma;Pediatric Hematology and Oncology;2021-06-02

4. Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening;PLOS ONE;2021-03-10

5. The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer;International Journal of Molecular Sciences;2021-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3